Department of Pharmaceuticals accords approval to four states under Promotion of Medical Devices Park scheme

Published On 2022-04-13 11:38 GMT   |   Update On 2022-04-13 15:01 GMT
Advertisement

New Delhi: Facilitating the development of the medical device sector, Department of Pharmaceuticals (DoP), Government of India has recently accorded approval to four states under the scheme 'Promotion of Medical Devices Park'.

The approval has been accorded to Madhya Pradesh, Tamil Nadu, Himachal Pradesh and Uttar Pradesh.

Following are the details of the approval accorded to the states under the scheme "Promotion of Medical Devices Park":

Advertisement

SI. No

Name of the State accorded approval

Location of the Park

Area of the Park, as proposed by the State

(in acres)

Total project cost (in cr.)

Common Infrastructure Facilities (CIF) cost to be covered under the Park Scheme (in cr.)

Maximum Grant-in-aid under the Scheme (in Cr.)

Physical Infrastructure cost (to be borne by the state)

(in Cr.)

Total amount to be borne by the State (State contribution for CIF and Physical Infrastructure)

(in cr.)

1.

Madhya Pradesh

Pithampur-Dhar-Mhow Region, Vikram Udyogpuri Limited, Ujjain District

360.06

222.77

155.63

100

34.47

122.77

2.

Tamil Nadu

Oragadam Industrial Corridor, Vaipur & Mathur villages, Kancheepuram District

350.00

212.40

153.33

100

59.07

112.40

Himachal Pradesh

Baddi Barotiwala Nalagarh (BBN Area), Tehsil Nalagarh, Solan District

265.75

349.83

157.64

100

192.19

249.83

4

Uttar Pradesh

Sector 28 of YEIDA Phase I, Gautam Buddh Nagar District

350.00

435.94

214.17

100

221.77

335.94

Recognizing the need for higher levels of investments for the creation of proper infrastructure in the sector, the Department of Pharmaceuticals had notified the Scheme for "Promotion of Medical Device Parks" with the following objectives:

a. Easy access to standard testing and infrastructure facilities through creation of world class common infrastructure facilities for increased competitiveness will result into significant reduction of the cost of production of medical devices leading to better availability and affordability of medical devices in the domestic market.

b. Reaping the benefits arising due to optimization of resources and economies of scale.

To view the full notice, click on the following link:

https://medicaldialogues.in/pdf_upload/medicald-device-174240.pdf

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News